SD Biosensor, Inc. (KRX:137310)

Market Cap	980.88B -17.8%
Revenue (ttm)	710.58B +2.3%
Net Income	-512.11B
EPS	-4,279.00
Shares Out	119.62M
PE Ratio	n/a
Forward PE	n/a
Dividend	200.00 (2.44%)
Ex-Dividend Date	Mar 30, 2026

Volume	113,161
Average Volume	102,971
Open	7,810.00
Previous Close	7,890.00
Day's Range	7,810.00 - 8,200.00
52-Week Range	7,100.00 - 13,550.00
Beta	0.73
RSI	55.37
Earnings Date	Feb 20, 2026

About SD Biosensor

SD Biosensor, Inc., together with its subsidiaries, operates as an in-vitro diagnostic company in South Korea, India, Asia, Europe, the Americas, and Africa. The company offers STANDARD Q, which provides rapid diagnostic products; STANDARD F, a fluorescence immunodiagnostic system for various qualitative and quantitative diagnosis items; STANDARD E, an enzyme immunoassay diagnosis for large-volume tests; and STANDARD M, a field molecular diagnosis system for infectious disease diagnosis, drug resistance, and genetic testing. It also provides ST...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1999
• Employees: 576
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 137310

Financial Performance

In 2025, SD Biosensor's revenue was 710.58 billion, an increase of 2.30% compared to the previous year's 694.57 billion. Losses were -512.11 billion, 420.4% more than in 2024.